We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Graduated Embryo Score (GES) in the Fresh Cycle Predicts Outcome From Frozen Embryo Transfer (GES/FET)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00694434
First Posted: June 10, 2008
Last Update Posted: June 10, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sher Institute for Reproductive Medicine, Las Vegas
  Purpose
Evaluation of embryo quality in the fresh cycle as a predictor of outcome from frozen embryo transfer.

Condition
Infertility

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Graduated Embryo Score (GES) Int he Fresh Cycle Predicts Outcome From Frozen Embryo Transfer

Further study details as provided by Sher Institute for Reproductive Medicine, Las Vegas:

Primary Outcome Measures:
  • On-going gestation (beyond 8 wks) [ Time Frame: Fetal heart activity at 8 weeks of gestation ]

Secondary Outcome Measures:
  • Implantation rate (gestational sacs/ embryos transferred) [ Time Frame: 8 weeks of gestation ]

Enrollment: 183
Study Start Date: January 2002
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Patients with 2 or more frozen blastocyst that scored GES 70 or better in the fresh cycle.
2
Patients with 2 or more frozen blastocysts scoring GES <70 in the fresh cycle.

Detailed Description:
Outcomes from frozen embryo transfer reviewed based on the quality of the embryos in the ftresh cycle as assessed by the Graduatede embryo score.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 44 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All IVF patients at our center between 2002 and 2007 with at least 2 frozen blastocysts undergoing frozen embryo transfer.
Criteria

Inclusion Criteria:

  • 2 frozen blastocysts
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00694434


Locations
United States, Nevada
Sher Institute for Reproductive Medicine
Las Vegas, Nevada, United States, 89118
Sponsors and Collaborators
Sher Institute for Reproductive Medicine, Las Vegas
Investigators
Principal Investigator: Jeffrey D Fisch, M.D. Sher Institute
  More Information

Responsible Party: Jeffrey Fisch, M.D., Sher Institute
ClinicalTrials.gov Identifier: NCT00694434     History of Changes
Other Study ID Numbers: 1-Fisch
First Submitted: June 6, 2008
First Posted: June 10, 2008
Last Update Posted: June 10, 2008
Last Verified: June 2008

Keywords provided by Sher Institute for Reproductive Medicine, Las Vegas:
Cryopreservation
Frozen embryo transfer
Graduated Embryo Score

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female